Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Ethosomes can safely and effectively deliver various drugs deep into the skin.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

New drugs for heart disease may be developed from molecules secreted by stem cells.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Using old drugs for new uses can help treat rare immune deficiencies.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Nanoparticles with more oleic acid improved the delivery and stability of the drug spironolactone.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

Pranlukast and mirabegron may work as new diabetes drugs.

The document concludes that a Quality Management System is crucial for maintaining product quality through innovation and proper technology transfer in the pharmaceutical industry.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.

Scientists created 3D hair-like structures that could help study hair growth and test treatments.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

New tests detect finasteride and dutasteride in urine quickly and easily.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

The conference reported improvements in muscle volume, skin cancer diagnosis, facial and vaginal rejuvenation, and hair growth using various laser treatments.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.